TVRD Cara Therapeutics, Inc. Gross Profit Rate

Corporate emblem and logo of Cara Therapeutics, Inc. (TVRD)

Cara Therapeutics Inc develops innovative selective agonists to combat renal pruritus. Competent management effectively engages with regulators, achieving its established goals. The gross profit margin helps assess the real value of the business, while 0.00 reflects the latest level of this metric. However, a reduction in research staff and the abandonment of several programs have limited internal development.

caratherapeutics.com (TVRD) Return on Gross Profit: for the period 07/04/2022 - 11/20/2026

Financial and market metric breakdowns for Cara Therapeutics Inc (TVRD)

- market value and analyst target forecast:
- cash position and cash flow details:
Fundamental valuation:TVRD Cara Therapeutics, Inc.
Flagship merchandise of Cara Corp

Gross margin determines production efficiency by measuring the portion of revenue remaining after direct product creation costs. Analyzing the gross profit margin allows for an assessment of the financial stability of Cara Therapeutics Inc (TVRD), where patent protection and the chronic nature of kidney diseases ensure a stable cash flow and high profitability for each unit of the drug sold.